Castillo-Arellano Jorge I, Stryker Zachary, Wyatt Michael D, León Francisco
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina 29208, United States.
ACS Med Chem Lett. 2024 Apr 3;15(5):610-618. doi: 10.1021/acsmedchemlett.3c00573. eCollection 2024 May 9.
Small molecule neurotransmitters containing amines are metabolized by monoamine oxidase (MAO) in the nervous system. Monoamine oxidase inhibitors are a valuable class of drugs prescribed for the management of neurological disorders, including depression. A series of halogenated flavonoids similar to the dietary flavonoid acacetin were designed as selective MAO-B inhibitors. MAO-A and -B inhibition of 36 halogenated flavones were tested. The halogens (fluorine and chlorine) were placed at positions 5 and 7 on ring A of the flavone scaffold. All compounds were selective MAO-B inhibitors with micro- and nanomolar IC values. Compounds , -, -, ,, and displayed inhibitory activity toward MAO-B with IC values between 16 to 74 nM. We conclude that halogenated flavonoids are promising molecules in pursuit of developing new agents for neurological disorders.
含胺的小分子神经递质在神经系统中由单胺氧化酶(MAO)代谢。单胺氧化酶抑制剂是一类用于治疗包括抑郁症在内的神经系统疾病的重要药物。设计了一系列类似于膳食黄酮刺槐素的卤代黄酮作为选择性MAO - B抑制剂。测试了36种卤代黄酮对MAO - A和 - B的抑制作用。卤素(氟和氯)位于黄酮骨架A环的5位和7位。所有化合物均为选择性MAO - B抑制剂,其IC值为微摩尔和纳摩尔级别。化合物 、 、 、 和 对MAO - B表现出抑制活性,IC值在16至74 nM之间。我们得出结论,卤代黄酮是开发用于神经系统疾病新药物的有前景的分子。